tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Nanjing Leads Biolabs Gains FDA Approval for Novel Autoimmune Drug
Company AnnouncementsNanjing Leads Biolabs Gains FDA Approval for Novel Autoimmune Drug
9d ago
9887
Nanjing Leads Biolabs Updates Articles of Association Post-Global Offering
PremiumCompany Announcements
Nanjing Leads Biolabs Updates Articles of Association Post-Global Offering
13d ago
9887
Nanjing Leads Biolabs Advances in Cancer Treatment with New Clinical Trial
PremiumCompany Announcements
Nanjing Leads Biolabs Advances in Cancer Treatment with New Clinical Trial
19d ago
9887
Innovative Pipeline and Promising Drug Candidates Drive Buy Rating for Nanjing Leads Biolabs Co., Ltd.
PremiumRatings
Innovative Pipeline and Promising Drug Candidates Drive Buy Rating for Nanjing Leads Biolabs Co., Ltd.
27d ago
Nanjing Leads Biolabs Reports Significant Progress in Cancer Therapy Development
PremiumCompany Announcements
Nanjing Leads Biolabs Reports Significant Progress in Cancer Therapy Development
1M ago
9887
Nanjing Leads Biolabs Advances LBL-034 to Phase II Trial
PremiumCompany AnnouncementsNanjing Leads Biolabs Advances LBL-034 to Phase II Trial
1M ago
9887
Nanjing Leads Biolabs Announces Upcoming Board Meeting for Interim Results
Premium
Company Announcements
Nanjing Leads Biolabs Announces Upcoming Board Meeting for Interim Results
1M ago
9887
Nanjing Leads Biolabs Exercises Over-allotment Option in Global Offering
Premium
Company Announcements
Nanjing Leads Biolabs Exercises Over-allotment Option in Global Offering
2M ago
9887

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >